Study of the role of CD4+CD45RClowTreg in regulating immune tolerance of rats undergoing liver transplantation
-
摘要:
目的 探讨CD4+CD45RClow调节性T细胞(Treg)在肝移植免疫耐受诱导中的作用。 方法 建立急性排斥反应(AR)[Lewis→Brown Norway(BN),AR组]与自发耐受(BN→Lewis,耐受组)大鼠肝移植模型,每组6只。并设立假手术组(对照组),Lewis大鼠和BN大鼠各3只。对各组大鼠肝组织进行病理学检查;检测各组大鼠外周血、移植肝、脾脏T细胞亚群和浆细胞样树突状细胞(pDC)的表达情况,分析pDC与CD4+CD45RClowTreg的相关性;检测各组大鼠移植肝和脾脏CD4、CD45RC、CD103的表达情况。 结果 AR组大鼠病理学主要表现为移植肝炎症细胞浸润和组织结构紊乱。与AR组大鼠比较,耐受组大鼠外周血CD4+CD25+Treg、CD8+Treg表达水平均升高(均为P < 0.05)。外周血CD4+CD25+Treg与CD8+Treg表达水平呈正相关(r=0.742,P=0.022)。AR组大鼠外周血CD4+CD45RChighT细胞水平高于耐受组和对照组大鼠(均为P < 0.05)。与AR组大鼠比较,耐受组大鼠脾脏CD4+CD45RClowTreg表达水平升高,外周血、移植肝、脾脏CD8+CD45RClowTreg表达水平均升高(均为P < 0.05)。与对照组和AR组大鼠比较,耐受组大鼠外周血CD8+CD45RClowTreg/CD8+T比值升高,外周血、移植肝、脾脏中pDC的表达水平均升高(均为P < 0.05);且CD4+CD45RClowTreg与pDC表达水平的变化呈正相关(r=0.506,P=0.016)。耐受组大鼠移植肝和脾脏CD4、CD45RC、CD103的表达均增多;而AR组大鼠移植肝CD4、CD45RC的表达增多,CD103表达降低。 结论 CD4+CD45RClowTreg是具有负向免疫调控作用的细胞亚群,与CD8+CD45RClowTreg及pDC等构成免疫耐受诱导的调节性细胞网络。 -
关键词:
- 肝移植 /
- 免疫耐受 /
- 排斥反应 /
- 调节性T细胞(Treg) /
- 树突状细胞 /
- CD45RC /
- CD4 /
- CD103 /
- 大鼠 /
- CD4+CD45RClowTreg /
- CD8+CD45RClowTreg
Abstract:Objective To investigate the role of CD4+CD45RClow regulatory T cell (Treg) in the immune tolerance induction of rats undergoing liver transplantation. Methods Liver transplantation rat models of acute rejection (AR) [Lewis→Brown Norway (BN), AR group] and spontaneous tolerance (BN→Lewis, tolerance group) were established, with 6 rats in each group. Moreover, 3 Lewis rats and 3 BN rats were assigned into the sham operation group (control group). The liver tissues of rats in each group were subject to pathological staining. The expression of T cell subsets and plasmacytoid dendritic cells (pDC) in the peripheral blood, liver graft and spleen of rats was detected in each group. The correlation between pDC and CD4+CD45RClowTreg was analyzed. The expression levels of CD4, CD45RC and CD103 in the liver graft and spleen of rats were quantitatively measured in each group. Results In the AR group, pathological manifestations mainly consisted of inflammatory cell infiltration and structure disorders of transplant liver. Compared with the AR group, the expression levels of CD4+CD25+Treg and CD8+Treg in the peripheral blood were significantly up-regulated in the tolerance group (all P < 0.05). In the peripheral blood, the expression level of CD4+CD25+Treg was positively correlated with that of CD8+Treg (r=0.742, P=0.022). In the AR group, the expression level of CD4+CD45RChighT cell in the peripheral blood was significantly higher than those in the tolerance and control groups (both P < 0.05). Compared with the AR group, the expression level of CD4+CD45RClowTreg in the spleen, and the expression levels of CD8+CD45RClowTreg in the peripheral blood, transplant liver and spleen were significantly up-regulated in the tolerance group (all P < 0.05). Compared with the control and AR groups, the ratio of CD8+CD45RClowTreg/CD8+T in the peripheral blood and the expression levels of pDC in the peripheral blood, transplant liver and spleen were all significantly up-regulated in the tolerance group (all P < 0.05). The expression level of CD4+CD45RClowTreg was positively correlated with the changes of pDC (r=0.506, P=0.016). The expression levels of CD4, CD45RC and CD103 in the transplant liver and spleen of rats were up-regulated in the tolerance group. In the AR group, the expression levels of CD4 and CD45RC were up-regulated, whereas that of CD103 was down-regulated. Conclusions CD4+CD45RClowTreg is a cell subgroup with negative immune regulation, which may construct a regulatory cell network of immune tolerance induction along with CD8+CD45RClowTreg and pDC. -
Key words:
- Liver transplantation /
- Immune tolerance /
- Rejection /
- Regulatory T cell (Treg) /
- Dendritic cell /
- CD45RC /
- CD4 /
- CD103 /
- Rat /
- CD4+CD45RClowTreg /
- CD8+CD45RClowTreg
-
图 3 各组大鼠CD4+CD45RClowTreg、CD8+CD45RClowTreg分析结果
注:A图为各组大鼠不同组织中CD4+CD45RClowTreg表达水平;B图为各组大鼠不同组织中CD8+CD45RClowTreg表达水平;C图为各组大鼠外周血CD4+CD45RClowTreg/CD4+T比值和CD8+CD45RClowTreg/CD8+T比值;与对照组比较,aP<0.05,与AR组比较,bP<0.05。
Figure 3. Analysis results of CD4+CD45RClowTreg and CD8+CD45RClowTreg of rats in each group
-
[1] 吕凌, 倪绪浩. 个体化免疫耐受的诱导与调节性T细胞[J]. 器官移植, 2020, 11(1): 8-12. DOI: 10.3969/j.issn.1674-7445.2020.01.002.LYU L, NI XH. Individualized induction of immune tolerance and regulatory T cell[J]. Organ Transplant, 2020, 11(1): 8-12. DOI: 10.3969/j.issn.1674-7445.2020.01.002. [2] AISSAOUI N, MORSHUIS M, MAOULIDA H, et al. Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes[J]. Eur J Cardiothorac Surg, 2018, 53(1): 170-177. DOI: 10.1093/ejcts/ezx258. [3] BÉZIE S, ANEGON I, GUILLONNEAU C. Advances on CD8+ Treg cells and their potential in transplantation[J]. Transplantation, 2018, 102(9): 1467-1478. DOI: 10.1097/TP.0000000000002258. [4] BARINOV A, GALGANO A, KRENN G, et al. CD4/CD8/dendritic cell complexes in the spleen: CD8+ T cells can directly bind CD4+ T cells and modulate their response[J]. PLoS One, 2017, 12(7): e0180644. DOI: 10.1371/journal.pone.0180644. [5] 白纯, 李先亮, 杨龙, 等. CD8+CD45RClow调节性T细胞在大鼠肝移植自然免疫耐受中的作用机制[J]. 中华实验外科杂志, 2019, 36(5): 849-851. DOI: 10.3760/cma.j.issn.1001-9030.2019.05.019.BAI C, LI XL, YANG L, et al. The mechanism of CD8+CD45RClow regulatory T cell in rat liver transplantation nature tolerance model[J]. Chin J Exp Surg, 2019, 36(5): 849-851. DOI: 10.3760/cma.j.issn.1001-9030.2019.05.019. [6] LI XL, MÉNORET S, BEZIE S, et al. Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance[J]. J Immunol, 2010, 185(2): 823-833. DOI: 10.4049/jimmunol.1000120. [7] 杨龙, 李先亮, 刘焕业, 等. Immutol诱导大鼠心脏移植物免疫耐受的研究[J]. 器官移植, 2019, 10(3): 288-294. DOI: 10.3969/j.issn.1674-7445.2019.03.011.YANG L, LI XL, LIU HY, et al. Immutol induces immune tolerance of cardiac grafts in rat models[J]. Organ Transplant, 2019, 10(3): 288-294. DOI: 10.3969/j.issn.1674-7445.2019.03.011. [8] 李先亮, 白纯, 杨龙, 等. 大鼠肝移植免疫耐受过程Th细胞和Treg细胞因子及信号通路蛋白的变化研究[J]. 器官移植, 2019, 10(4): 416-422. DOI: 10.3969/j.issn.1674-7445.2019.04.011.LI XL, BAI C, YANG L, et al. Changes of Th, Treg cytokines and signaling pathway proteins during immune tolerance process in rat models of liver transplantation[J]. Organ Transplant, 2019, 10(4): 416-422. DOI: 10.3969/j.issn.1674-7445.2019.04.011. [9] JOSIEN R, PANNETIER C, DOUILLARD P, et al. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats[J]. Transplantation, 1995, 60(10): 1131-1139. DOI: 10.1097/00007890-199511270-00013. [10] GARNIER AS, PLANCHAIS M, RIOU J, et al. Pre-transplant CD45RC expression on blood T cells differentiates patients with cancer and rejection after kidney transplantation[J]. PLoS One, 2019, 14(3): e0214321. DOI: 10.1371/journal.pone.0214321. [11] BOUCAULT L, LOPEZ ROBLES MD, THIOLAT A, et al. Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease[J]. Blood Adv, 2020, 4(11): 2501-2515. DOI: 10.1182/bloodadvances.2020001688. [12] MIYANARI N, YAMAGUCHI Y, MATSUNO K, et al. Persistent infiltration of CD45RC-CD4+T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion[J]. Hepatology, 1997, 25(4): 1008-1013. DOI: 10.1002/hep.510250436. [13] ZHANG X, MA J, LI H, et al. Overexpression of fibrinogen-like protein 2 alleviates acute rejection in rat models of liver transplantation[J]. Ann Transl Med, 2021, 9(5): 408. DOI: 10.21037/atm-20-7881. [14] 赵阳, 周林, 贺强. CD8+调节性T细胞诱导移植免疫耐受的研究进展[J]. 解放军医学院学报, 2020, 41(7): 743-745, 751. DOI: 10.3969/j.issn.2095-5227.2020.07.021.ZHAO Y, ZHOU L, HE Q. Research advances in immune tolerance in transplantation induced by CD8+ regulatory T cells[J]. Acad J Chin PLA Med Sch, 2020, 41(7): 743-745, 751. DOI: 10.3969/j.issn.2095-5227.2020.07.021. [15] 吴俣, 李佩璐, 葛军, 等. 嵌合抗原受体调节性T细胞免疫疗法在器官移植中的应用[J]. 器官移植, 2020, 11(5): 547-552. DOI: 10.3969/j.issn.1674-7445.2020.05.003.WU Y, LI PL, GE J, et al. Application of chimeric antigen receptor-regulatory T cell immunotherapy in organ transplantation[J]. Organ Transplant, 2020, 11(5): 547-552. DOI: 10.3969/j.issn.1674-7445.2020.05.003. [16] MACHICOTE A, BELÉN S, BAZ P, et al. Human CD8+HLA-DR+ regulatory T cells, similarly to classical CD4+Foxp3+ cells, suppress immune responses via PD-1/PD-L1 axis[J]. Front Immunol, 2018, 9: 2788. DOI: 10.3389/fimmu.2018.02788. [17] FLIPPE L, BÉZIE S, ANEGON I, et al. Future prospects for CD8+ regulatory T cells in immune tolerance[J]. Immunol Rev, 2019, 292(1): 209-224. DOI: 10.1111/imr.12812. [18] LIGOCKI AJ, NIEDERKORN JY. Advances on non-CD4+Foxp3+T regulatory cells: CD8+, type 1, and double negative T regulatory cells in organ transplantation[J]. Transplantation, 2015, 99(8): 1553-1559. DOI: 10.1097/TP.0000000000000813. [19] ZAPATA JM, PULIDO R, ACEVEDO A, et al. A novel marker for T cells at different maturation and activation stages[J]. J Immunol, 1994, 152(8): 3852-3861. http://www.ncbi.nlm.nih.gov/pubmed/8144955 [20] XYSTRAKIS E, DEJEAN AS, BERNARD I, et al. Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation[J]. Blood, 2004, 104(10): 3294-3301. DOI: 10.1182/blood-2004-03-1214. [21] LEMERLE M, GARNIER AS, PLANCHAIS M, et al. CD45RC expression of circulating CD8+ T cells predicts acute allograft rejection: a cohort study of 128 kidney transplant patients[J]. J Clin Med, 2019, 8(8): 1147. DOI: 10.3390/jcm8081147. [22] PICARDA E, BÉZIE S, BOUCAULT L, et al. Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cells[J]. JCI Insight, 2017, 2(3): e90088. DOI: 10.1172/jci.insight.90088. [23] NIEDERLOVA V, TSYKLAURI O, CHADIMOVA T, et al. CD8+ Tregs revisited: a heterogeneous population with different phenotypes and properties[J]. Eur J Immunol, 2021, 51(3): 512-530. DOI: 10.1002/eji.202048614. [24] BRUMMELMAN J, PILIPOW K, LUGLI E. The single-cell phenotypic identity of human CD8+ and CD4+ T cells[J]. Int Rev Cell Mol Biol, 2018, 341: 63-124. DOI: 10.1016/bs.ircmb.2018.05.007. [25] STOLP J, ZAITSU M, WOOD KJ. Immune tolerance and rejection in organ transplantation[J]. Methods Mol Biol, 2019, 1899: 159-180. DOI: 10.1007/978-1-4939-8938-6_12. [26] 孙彬, 魏玉香, 石炳毅. 树突状细胞分类及调节性树突状细胞获取方式的研究进展[J]. 器官移植, 2019, 10(2): 198-201. DOI: 10.3969/j.issn.1674-7445.2019.02.014.SUN B, WEI YX, SHI BY. Research progress on the classification of dendritic cell and the acquisition methods of regulatory dendritic cell[J]. Organ Transplant, 2019, 10(2): 198-201. DOI: 10.3969/j.issn.1674-7445.2019.02.014. [27] LI H, SHI B. Tolerogenic dendritic cells and their applications in transplantation[J]. Cell Mol Immunol, 2015, 12(1): 24-30. DOI: 10.1038/cmi.2014.52.